These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22149406)
1. Case identification of subjects with airflow limitations using the handheld spirometer "Hi-Checker™" : comparison against an electronic desktop spirometer. Nishimura K; Nakayasu K; Kobayashi A; Mitsuma S COPD; 2011 Dec; 8(6):450-5. PubMed ID: 22149406 [TBL] [Abstract][Full Text] [Related]
2. Performance of a new screening spirometer at a community health fair. Schoh RJ; Fero LJ; Shapiro H; Aslor JP; Kaelin OJ; Rollins DR; Petty TL Respir Care; 2002 Oct; 47(10):1150-7. PubMed ID: 12354333 [TBL] [Abstract][Full Text] [Related]
3. Comparison of a new desktop spirometer (Spirospec) with a laboratory spirometer in a respiratory out-patient clinic. Swart F; Schuurmans MM; Heydenreich JC; Pieper CH; Bolliger CT Respir Care; 2003 Jun; 48(6):591-5. PubMed ID: 12780945 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease]. Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of airflow limitation among employees in Norwegian smelters: a longitudinal study. Søyseth V; Johnsen HL; Bugge MD; Hetland SM; Kongerud J Occup Environ Med; 2011 Jan; 68(1):24-9. PubMed ID: 20798007 [TBL] [Abstract][Full Text] [Related]
6. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision? Roche N; Dalmay F; Perez T; Kuntz C; Vergnenègre A; Neukirch F; Giordanella JP; Huchon G Respir Med; 2008 Nov; 102(11):1568-74. PubMed ID: 18657959 [TBL] [Abstract][Full Text] [Related]
7. Validation of "lung age" measured by spirometry and handy electronic FEV1/FEV6 meter in pulmonary diseases. Toda R; Hoshino T; Kawayama T; Imaoka H; Sakazaki Y; Tsuda T; Takada S; Kinoshita M; Iwanaga T; Aizawa H Intern Med; 2009; 48(7):513-21. PubMed ID: 19336952 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC. Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365 [TBL] [Abstract][Full Text] [Related]
9. Comparison between peak expiratory flow and FEV(1) measurements on a home spirometer and on a pneumotachograph in children with asthma. Brouwer AF; Roorda RJ; Brand PL Pediatr Pulmonol; 2007 Sep; 42(9):813-8. PubMed ID: 17639585 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of office spirometry performed by trained primary-care physicians using the MIR Spirobank hand-held spirometer. Degryse J; Buffels J; Van Dijck Y; Decramer M; Nemery B Respiration; 2012; 83(6):543-52. PubMed ID: 22269344 [TBL] [Abstract][Full Text] [Related]
11. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
12. Detection of airflow limitation using a handheld spirometer in a primary care setting. Ching SM; Pang YK; Price D; Cheong AT; Lee PY; Irmi I; Faezah H; Ruhaini I; Chia YC Respirology; 2014 Jul; 19(5):689-93. PubMed ID: 24708063 [TBL] [Abstract][Full Text] [Related]
13. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Castillo D; Guayta R; Giner J; Burgos F; Capdevila C; Soriano JB; Barau M; Casan P; Respir Med; 2009 Jun; 103(6):839-45. PubMed ID: 19200706 [TBL] [Abstract][Full Text] [Related]
14. Comparison of a portable, pneumotach flow-sensor-based spirometer (Spirofy™) with the vitalograph alpha Touch™ spirometer in evaluating lung function in healthy individuals, asthmatics, and COPD patients-a randomized, crossover study. Talwar D; Balamurugan S; Modi M; Salvi S; Lopez M; Shah R; Vaidya A; Barne M; Madas S; Kulkarni N; Sawant S; Gogtay J BMC Pulm Med; 2024 May; 24(1):230. PubMed ID: 38730359 [TBL] [Abstract][Full Text] [Related]
15. Remote daily real-time monitoring in patients with COPD --a feasibility study using a novel device. Sund ZM; Powell T; Greenwood R; Jarad NA Respir Med; 2009 Sep; 103(9):1320-8. PubMed ID: 19375294 [TBL] [Abstract][Full Text] [Related]
16. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD? Medbø A; Melbye H Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575 [TBL] [Abstract][Full Text] [Related]
17. [The rate of airflow limitation among the elderly undergoing spirometry in a university hospital]. Tojo N; Umino T; Miyasaka N Rinsho Byori; 2004 Aug; 52(8):649-54. PubMed ID: 15478620 [TBL] [Abstract][Full Text] [Related]
18. Comparison of a new desktop spirometer (Diagnosa) with a laboratory spirometer. Maree DM; Videler EA; Hallauer M; Pieper CH; Bolliger CT Respiration; 2001; 68(4):400-4. PubMed ID: 11464088 [TBL] [Abstract][Full Text] [Related]
19. [Measuring breathing pattern in patients with chronic obstructive pulmonary disease by electrical impedance tomography]. Balleza M; Calaf N; Feixas T; González M; Antón D; Riu PJ; Casan P Arch Bronconeumol; 2009 Jul; 45(7):320-4. PubMed ID: 19497652 [TBL] [Abstract][Full Text] [Related]
20. Reproducibility and validity of a handheld spirometer. Barr RG; Stemple KJ; Mesia-Vela S; Basner RC; Derk SJ; Henneberger PK; Milton DK; Taveras B Respir Care; 2008 Apr; 53(4):433-41. PubMed ID: 18364054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]